Company: BIAF
Filing Date: 2025-04-16
Form Type: CORRESP
Source: 0001641172-25-005116
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-16
Form: CORRESP
Chunk 0
---
April 16, 2025

VIA EDGAR

United States Securities

and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Margaret Sawicki

| Re: | bioAffinity           
 Technologies, Inc.    
 Registration          
 Statement on Form S-1 
 Filed                 
 April 11, 2025        |
|:----|:----------------------|
|     | File                  
 No: 333-286497        |

Dear Ms. Sawicki:

bioAffinity Technologies, Inc. (the “ Registrant”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-286497), be accelerated by the U.S. Securities and Exchange Commission (the “ Commission”) to become effective on Friday, April 16, 2025, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.

The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

The Registrant hereby authorizes Leslie Marlow or Melissa Palat Murawsky of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Leslie Marlow at (212) 885-5358 or Melissa Palat Murawsky at (215) 569-5732 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted.

| Very             
 truly yours,     |                   |
| BIOAFFINITY      
 TECHNOGIES, INC. |                   |
| By:              | /s/               
 Maria Zannes      |
| Name:            | Maria             
 Zannes            |
| Title:           | Chief             
 Executive Officer |

| cc: | Leslie Marlow,                 
 Blank Rome LLP                 |
|     | Melissa                        
 Palat Murawsky, Blank Rome LLP |